Icrucumab Biosimilar

REQUEST MORE INFO
Catalogue No: abx831212
Price: US$391.50
(Size: 1 mg)

Orders to United States ship from United States

Click on the image to see the image legend

Available Options

* Size:



Add to Cart Buy It Now GET A QUOTE

Documents

Datasheet SDS
Icrucumab is a fully Human monoclonal antibody biosimilar expressed in CHO cells, targeting FLT1/VEGFR-1, for use in laboratory research applications. This product is not suitable for use as medicines or in human, therapeutic or diagnostic applications.

Icrucumab is under investigation in clinical trial NCT01111604 (A Study of IMC-1121B or IMC-18F1 in Colorectal Cancer).

Target FLT1/VEGFR-1
Research Area Biosimilars
Clonality Monoclonal
Reactivity Human
Expression Recombinant
Tested Applications ELISA
Host Human
Recommended dilutions Optimal dilutions/concentrations should be determined by the end user.
Conjugation Unconjugated
Isotype IgG1 Kappa
Form Liquid
Purity > 95%
Purification Purified from cell culture supernatants by Protein A/G chromatography.
Storage Store at 4°C for up to 2 weeks. Aliquot and store at -20°C for long term storage. Avoid repeated freeze/thaw cycles.
Shelf Life 12 months.
Buffer 0.01 M PBS, pH 7.4.
CAS Number 1024603-92-6
Concentration Batch-dependent, typically between 0.5-2.0 mg/ml.
Availability Shipped within 5-10 working days.
Note THIS PRODUCT IS FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC, THERAPEUTIC OR COSMETIC PROCEDURES. NOT FOR HUMAN OR ANIMAL CONSUMPTION.
Research Articles on FLT1/VEGFR-1


Write a review

Tags:
(Click to show)